EUR 1.19
(16.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - USD | N/A |
2022 | - USD | 0.0% |
2021 | - USD | N/A |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BioNTech SE | 3.21 Billion EUR | 100.0% |
CureVac N.V. | -70.6 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 271.9 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 271.9 Million EUR | 100.0% |
BRAIN Biotech AG | 30.12 Million EUR | 100.0% |
Formycon AG | 23.3 Million EUR | 100.0% |
Heidelberg Pharma AG | 6.6 Million EUR | 100.0% |
Medigene AG | 4.39 Million EUR | 100.0% |